SBRA
Sabra Health Care Reit, Inc. Real Estate Real Estate Investment Trusts Russell 3000
$19.74Close
$5.0BMarket cap
$16.45 – $22.0652-week range
Nov 2, 2026Next report · after the close
Highlights
Cautions
- Not in an uptrend 4 of 8 trend conditions
- Earnings shrinking EPS −137% year on year
- Results soon Nov 2, 2026, in 1 day
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
11%
1wk
up 0.9%
price change
1mo
up 0.1%
price change
12-month return
up 20%
market up 11% ·
its own up 11%
F-score
—
— Not assessed
Altman Z
—
Unknown
P/E
31.9×
price / earnings
PEG
1.72
P/E / EPS growth
P/B
1.8×
price / book
Earnings yield
up 3.6%
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
up 25%
year on year
EPS growth
down 137%
latest quarter · -132 pts
Sales growth
up 63%
latest quarter · +12 pts
ROE
up 6%
return on equity
Free cash margin
up 98%
$348.6M FCF
D/E
0.90
long-term debt / equity
Net debt / EBITDA
5.4×
Interest cover
2.4×EBIT / interest
Trade setup
ATR%
2.2%
$0.44 a day · 2×ATR $18.86
RS
54 / 99
vs the universe
Trend
4 / 8
trend template
Relative volume
0.9×
vs 50-day average
Up/down volume
0.70
50 sessions
Implied move
—
no option chain · report Nov 2, 2026
Trend template · 4 of 8
- Price above the 150 and 200-day averages: fails
- 150-day average above the 200-day: passes
- 200-day average rising for a month: passes
- 50-day average above the 150 and 200-day: passes
- Price above the 50-day average: fails
- At least 30% above the 52-week low: fails
- Within 25% of the 52-week high: passes
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Heavily indebted Net debt is 5.4 times EBITDA — roughly 5 years of earnings before interest, tax and depreciation to repay borrowings in full.
- Shareholders diluted The share count rose 5.9% over the year, from 238m to 252m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 3, 2026
Results reaction
Aug 3, 2026-6% vs market2 sessions after results
Financials
- Net 44%
- Free cash 98%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $156.0M | $155.5M | $186.7M | $236.2M | $284.6M | $356.9M |
| Net income | $138.4M | -$113.3M | -$77.6M | $13.8M | $126.7M | $155.6M |
| Net margin | 89% | -73% | -42% | 6% | 45% | 44% |
| Earnings per share | $0.67 | -$0.52 | -$0.34 | $0.06 | $0.54 | $0.64 |
| Free cash flow | $354.9M | $356.4M | $315.7M | $300.6M | $310.5M | $348.6M |
| Free cash margin | 227% | 229% | 169% | 127% | 109% | 98% |
| Cash | $59.1M | $112.0M | $49.3M | $41.3M | $60.5M | $71.5M |
| Long-term debt | $2.4B | $2.4B | $2.5B | $2.4B | $2.4B | $2.5B |
| Shareholders' equity | $3.4B | $3.4B | $3.1B | $2.8B | $2.7B | $2.8B |
| Shares outstanding | 210.56m | 230.40m | 231.01m | 231.27m | 237.59m | 251.70m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 3, 2026 | Quarterly ↗ | Jun 30, 2026 | 34d |
| Apr 29, 2026 | Quarterly ↗ | Mar 31, 2026 | 29d |
| Feb 12, 2026 | Annual ↗ | Dec 31, 2025 | 43d |
| Nov 5, 2025 | Quarterly ↗ | Sep 30, 2025 | 36d |
| Aug 4, 2025 | Quarterly ↗ | Jun 30, 2025 | 35d |
| May 5, 2025 | Quarterly ↗ | Mar 31, 2025 | 35d |
| Feb 19, 2025 | Annual ↗ | Dec 31, 2024 | 50d |
| Oct 31, 2024 | Quarterly ↗ | Sep 30, 2024 | 31d |
| Aug 7, 2024 | Quarterly ↗ | Jun 30, 2024 | 38d |
| May 8, 2024 | Quarterly ↗ | Mar 31, 2024 | 38d |
| Feb 27, 2024 | Annual ↗ | Dec 31, 2023 | 58d |
| Nov 6, 2023 | Quarterly ↗ | Sep 30, 2023 | 37d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 3, 2026 | Results · Regulation FD ↗ |
| Jul 21, 2026 | Regulation FD ↗ |
| Jun 17, 2026 | Shareholder vote ↗ |
| May 28, 2026 | Regulation FD ↗ |
| Apr 29, 2026 | Results · Regulation FD ↗ |
| Feb 12, 2026 | Results · Regulation FD ↗ |
| Jan 5, 2026 | Director or officer change · Regulation FD ↗ |
| Nov 5, 2025 | Results · Regulation FD ↗ |
| Aug 5, 2025 | Material agreement · Agreement ended ↗ |
| Aug 4, 2025 | Results · Regulation FD ↗ |
| Jul 31, 2025 | Material agreement · New obligation · Other events ↗ |
| Jun 30, 2025 | Other events ↗ |